{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:56:14Z","timestamp":1779918974296,"version":"3.53.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T00:00:00Z","timestamp":1072051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T00:00:00Z","timestamp":1072051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1038\/sj.jp.7211018","type":"journal-article","created":{"date-parts":[[2004,1,16]],"date-time":"2004-01-16T14:09:40Z","timestamp":1074262180000},"page":"24-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Effect of Beginning Recombinant Erythropoietin Treatment Within the First Week of Life, Among Very-Low-Birth-Weight Neonates, on \u201cEarly\u201d and \u201cLate\u201d Erythrocyte Transfusions: A Meta-Analysis"],"prefix":"10.1038","volume":"24","author":[{"given":"Anne C","family":"Kotto-Kome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene A","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,12,22]]},"reference":[{"key":"BF7211018_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1046\/j.1537-2995.2001.41030406.x","volume":"41","author":"EC Vamvakas","year":"2001","unstructured":"Vamvakas EC, Strauss RG . Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 2001;41:406\u2013415.","journal-title":"Transfusion"},{"key":"BF7211018_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0045-9380(99)80055-3","volume":"29","author":"SE Juul","year":"1999","unstructured":"Juul SE . Erythropoietin in the neonate. Curr Prob Pediatr 1999;29:133\u2013149.","journal-title":"Curr Prob Pediatr"},{"key":"BF7211018_CR3","first-page":"405","volume-title":"Hematologic Problems of the Neonate","author":"RG Strauss","year":"2000","unstructured":"Strauss RG . Blood banking and transfusion issues in perinatal medicine. In: Christensen RD, editor. Hematologic Problems of the Neonate. Philadelphia, PA: WB Saunders Co.; 2000. p. 405\u2013426."},{"key":"BF7211018_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1203\/00006450-200008000-00002","volume":"48","author":"A Zipursky","year":"2000","unstructured":"Zipursky A . Erythropoietin therapy for premature infants: cost without benefit? Pediatr Res 2000;48:136.","journal-title":"Pediatr Res"},{"key":"BF7211018_CR5","unstructured":"Mulrow CD, Oxman AD, editors. Cochrane. Collaborative Handbook [updated 21 Oct 1996]. Available in the Cochrane Library [database on disk and CD-ROM]. The Cochrane Collaboration; issue 3. Oxford Updated software; Updated quarterly. Available from: BMJ Publishing Group, London 1996."},{"key":"BF7211018_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.68.3_Spec_No.291","volume":"68","author":"A Emmerson","year":"1993","unstructured":"Emmerson A, Coles H, Stern C, Pearson T . Double-blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993;68:291\u2013296.","journal-title":"Arch Dis Child"},{"key":"BF7211018_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1203\/00006450-199311000-00022","volume":"34","author":"V Soubasi","year":"1993","unstructured":"Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D . In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res 1993;34:675\u2013679.","journal-title":"Pediatr Res"},{"key":"BF7211018_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0022-3476(95)70313-6","volume":"127","author":"V Soubasi","year":"1995","unstructured":"Soubasi V, Kremenopoulos G, Diamanti E, Tsantali C, Sarafidis K, Tsakiris D . Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr 1995;127:291\u2013297.","journal-title":"J Pediatr"},{"key":"BF7211018_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0022-3476(95)70462-0","volume":"126","author":"R Ohls","year":"1995","unstructured":"Ohls R, Osborne K, Christensen R . Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr 1995;126:421\u2013426.","journal-title":"J Pediatr"},{"key":"BF7211018_CR10","first-page":"739","volume":"9","author":"R Lauterbach","year":"1995","unstructured":"Lauterbach R, Kachlik P, Pawlik D, Bajorek I . Recombinant human erythropoietin in the treatment of anemia of prematurity. Pediatr Pols 1995;9:739\u2013744.","journal-title":"Pediatr Pols"},{"key":"BF7211018_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0022-3476(97)70089-1","volume":"131","author":"R Ohls","year":"1997","unstructured":"Ohls R, Harcum J, Schibler K, Christensen R . The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750\u2009grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 1997;131:661\u2013665.","journal-title":"J Pediatr"},{"key":"BF7211018_CR12","first-page":"191","volume":"43","author":"V Lima-Roger","year":"1998","unstructured":"Lima-Roger V, Torres-Montes A, Espinosa S, et al. Efficacy of treating very low birth weight and critical ill neonates with erythropoietin in the first 72\u2009h of age: a randomized, placebo-controlled trial. Sangre 1998;43:191\u2013195.","journal-title":"Sangre"},{"key":"BF7211018_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1542\/peds.105.5.1066","volume":"105","author":"H Donato","year":"2000","unstructured":"Donato H, Vain N, Rendo P, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatr 2000;105:1066\u20131072.","journal-title":"Pediatr"},{"key":"BF7211018_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1542\/peds.108.4.934","volume":"108","author":"R Ohls","year":"2001","unstructured":"Ohls R, Ehrenkranz R, Wright L, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: A multicenter, randomized, controlled trial. Pediatrics 2001;108:934\u2013942.","journal-title":"Pediatrics"},{"key":"BF7211018_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000419541","volume":"8","author":"M Obladen","year":"1991","unstructured":"Obladen M, Maier R, Grauel E, et al. Efficacy and Safety of recombinant human erythropoietin to prevent anemia of prematurity. Contrib Nephrol 1991;8:314\u2013326.","journal-title":"Contrib Nephrol"},{"key":"BF7211018_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199404283301701","volume":"330","author":"R Maier","year":"1994","unstructured":"Maier R, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330:1173\u20131178.","journal-title":"N Engl J Med"},{"key":"BF7211018_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1067\/mpd.2002.124309","volume":"141","author":"R Maier","year":"2002","unstructured":"Maier R, Obladen M, Muller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000\u2009g. J Pediatr 2002;141:8\u201315.","journal-title":"J Pediatr"},{"key":"BF7211018_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1695-4033(00)77451-0","volume":"53","author":"M De la Torre","year":"2000","unstructured":"De la Torre M, Gascon F, Zapatero M, Guzman J, Huertas D, Ruiz D Jaraba P . Prophylaxis of anemia of prematurity with erythropoietin. Case control study. An Esp Pediatr 2000;53:243\u2013248.","journal-title":"An Esp Pediatr"},{"key":"BF7211018_CR19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0929-693X(99)80586-7","volume":"6","author":"A Trenseteaux","year":"1999","unstructured":"Trenseteaux A, Egreteau L, Santerne B, Morville P . Recombinant human erythropoietin in preterm infants: evaluation of one year of experience. Arch Pediatr 1999;6:944\u2013951.","journal-title":"Arch Pediatr"},{"key":"BF7211018_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0929-693X(00)00210-4","volume":"8","author":"S Hays","year":"2001","unstructured":"Hays S, Guy B, Boulard M, et al. Transfusion malgr\u00e9erythropo\u00efetine recombinante: \u00e9chec ou limite du traitement? Etude d'une cohorte annuelle de poids de naissance inf\u00e9rieur a 1500\u2009g. Arch Pediatr 2001;8:355\u2013360.","journal-title":"Arch Pediatr"},{"key":"BF7211018_CR21","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0929-693X(01)00665-0","volume":"8","author":"S Klosowski","year":"2001","unstructured":"Klosowski S, Djebara A, Bachiri A, Haouari N, Thelliez P, Morisot C . An\u00e9mie du pr\u00e9matur\u00e9 et traitement par erythropo\u00efetine humaine recombinante (rHuEPO): Quel b\u00e9n\u00e9fice? Arch Pediatr 2001;8:1399\u20131400.","journal-title":"Arch Pediatr"},{"key":"BF7211018_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF02722624","volume":"69","author":"B Atasay","year":"2002","unstructured":"Atasay B, Gunlemez A, Akar N, Arsan S . Does early erythropoietin therapy decrease transfusions in anemia of prematurity? Indian J Pediatr 2002;69:389\u2013391.","journal-title":"Indian J Pediatr"},{"key":"BF7211018_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0022-3476(05)82552-1","volume":"121","author":"V Carnielli","year":"1992","unstructured":"Carnielli V, Montini G, Da Riol R, Dall' Amico R, Cantarutti F . Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992;121:98\u2013102.","journal-title":"J Pediatr"},{"key":"BF7211018_CR24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1046\/j.1440-1754.2001.00667.x","volume":"37","author":"C Yeo","year":"2001","unstructured":"Yeo C, Choo S, Ho L . Effect of recombinant human erythropoietin on transfusion needs in preterm infants. J Paediatr Child Health 2001;37:352\u2013358.","journal-title":"J Paediatr Child Health"},{"key":"BF7211018_CR25","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0022-3476(98)70320-8","volume":"132","author":"R Maier","year":"1998","unstructured":"Maier R, Obladen M, Kattner E, et al. High-versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr 1998;132:866\u2013870.","journal-title":"J Pediatr"},{"key":"BF7211018_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1542\/peds.104.2.210","volume":"104","author":"M Brown","year":"1999","unstructured":"Brown M, Keith III J . Comparison between two and five doses a week of recombinant human erythropoietin of anemia of prematurity: a randomized trial. Pediatrics 1999;104:210\u2013215.","journal-title":"Pediatrics"},{"key":"BF7211018_CR27","first-page":"83","volume":"2","author":"M Serra","year":"2000","unstructured":"Serra M, Espallargues M . Metaan\u00e1lisis de ensayos cl\u00ednicos. Pharm Care Esp 2000;2:83\u201392.","journal-title":"Pharm Care Esp"},{"key":"BF7211018_CR28","unstructured":"Petitti D . Meta-Analysis, decision analysis, cost-effectiveness analysis: methods for quantitative synthesis in medicine. 2nd ed. New York Oxford: Oxford University Press; 2000: 75\u2013118."},{"key":"BF7211018_CR29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1542\/peds.93.6.918","volume":"93","author":"MP Meyer","year":"1994","unstructured":"Meyer MP, Meyer JH, Commeford A, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double blind, placebo-controlled study. Pediatrics 1994;93:918\u2013923.","journal-title":"Pediatrics"},{"key":"BF7211018_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0022-3476(95)70561-9","volume":"126","author":"DA Lee","year":"1995","unstructured":"Lee DA, Slagel TA, Jackson TM, Evans CS . Reducing blood donor exposure in low birth weight infants by the use of older, unwashed packed red blood cells. J Pediatr 1995;126:280\u2013286.","journal-title":"J Pediatr"},{"key":"BF7211018_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0022-3476(00)70104-1","volume":"136","author":"RG Strauss","year":"2000","unstructured":"Strauss RG, Burmeister LF, Johnson K, Cress G, Cordle D . Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 2000;136:215\u2013219.","journal-title":"J Pediatr"},{"key":"BF7211018_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0095-5108(05)70045-2","volume":"27","author":"RK Ohls","year":"2000","unstructured":"Ohls RK . The use of erythropoietin in neonates. Clin Perinatol 2000;27:681\u2013696.","journal-title":"Clin Perinatol"},{"key":"BF7211018_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0095-5108(18)30274-4","volume":"22","author":"EM Bifano","year":"1995","unstructured":"Bifano EM, Curran TR . Minimizing donor bloods exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 1995;22:657\u2013669.","journal-title":"Clin Perinatol"},{"key":"BF7211018_CR34","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1542\/peds.106.2.e19","volume":"106","author":"JC Lin","year":"2000","unstructured":"Lin JC, Strauss RG, Kulhavy JC, et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 2000;106:E19.","journal-title":"Pediatrics"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7211018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211018","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:15:27Z","timestamp":1647602127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7211018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,22]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["BF7211018"],"URL":"https:\/\/doi.org\/10.1038\/sj.jp.7211018","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,22]]},"assertion":[{"value":"22 December 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}